Reuters report cited by Mylan executive chairman in letter to Teva CEO - Reuters News Agency
Teva Pharmaceutical Industries Ltd | Reuters
Teva shares tumble amid political battle, doubt from Moody's
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharmaceutical Industries Ltd | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OMAQFWFHNJDZCDZKKO5DWLBG4.jpg "Teva Israel enters medical cannabis market with new partnership | Reuters")
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 By Reuters
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
GSK's $235 million verdict revived against Teva, again | Reuters.com
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
Teva buys Anda for $500 million - ISRAEL21c
Teva Pharm woes seen denting Israeli exports, economic growth By Reuters
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Shloma Yanai (R), CEO of Teva Pharmaceutical Industries Ltd. and Hans-Joachim Ziems, chairman of VEM Holding exchange a handshake prior to a news conference in Cologne March 18, 2010. Teva Pharmaceutical on
What's 'down' with Teva? - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ANJL4AXVTBOMDKS2X4DIJZXZAY.jpg "Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters")
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Stops Production At US Plant After FDA Concerns: Report
Outrage as Teva charges $18,275 for generic drug in US - The Jerusalem Post
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
